Tumor Ablation Market is expected to reach US$ 585.1 Mn by 2026 at a CAGR of 12.5 % during the forecast period. Tumor ablation is a minimally invasive cancer procedure. That is generally used in the treatment of tumors of liver, kidney, bone, and lung. In the tumor ablation procedure, special probes are used to burn or freeze tumor without the surgery. Tumour ablation is a device operated to treat cancerous malignancy. Tumor ablation is the process of removing the cancerous cells from the body.
High prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis), the Rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research would create commercial market opportunities. The hugely unused markets in the developing countries are creating a lot of opportunities for the tumor ablation market. Furthermore, unfavorable reimbursement scenario and cost containment measures adopted by a government are the major hindrance of the market growth.
REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/12788
Tumor Ablation market is segmented by technology, mode of treatment, application, and region. Among technology, microwave ablation and radiofrequency (RF) ablation is expected to grow at the fastest rate owing various benefits offered by this technology. This technology would continue to dominate the market during the forecast period owing to increasing demand for minimally invasive cancer procedures. Radiofrequency ablation technology is the most commonly used therapy for liver cancer. It will grow at a significant rate due to approximately 85 percent and more success rate for eliminating small liver tumors. Among applications, liver cancer segment is predicted to grow at fastest rate due to the rise in the incidence of the bile duct and primary liver cancer.
Among regions, the North America region is expected to grow at the highest CAGR during the forecast period due to the remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology. The APAC region is expected to grow at the highest CAGR during the forecast period due to the increasing elderly population in the region. The high percentage of the elderly population in developing countries such as China and Japan are increasing the incidence of major types of cancer in the Asia Pacific region. Rising per capita income, rapid urbanization, and expansion of advanced healthcare facilities in developing economies are likely to offer profitable opportunities to vendors in tumor ablation market.
The key players of the tumor ablation market include Medtronic plc (Ireland) , Angiodynamics, Inc. (U.S.), Koninklijke Philips N.V, Spectranetics, Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.)
In the tumor ablation market, Medtronic plc holds the leadership position due to production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market.
DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/12788
Scope of the Tumor Ablation Market :
• Tumor Ablation Market, by Technology
• Radiofrequency (RF) Ablation
• Microwave Ablation
• Other Technologies
• Tumor Ablation Market, by Mode of Treatment
• Percutaneous Ablation
• Laparoscopic Ablation
• Surgical Ablation
• Tumor Ablation Market, by Application
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastasis
• Tumor Ablation Market by region
• North America
• Latin America
Key Players- Tumor Ablation Market
• Medtronic plc
• Angiodynamics, Inc.
• Koninklijke Philips N.V
• Spectranetics, Boston Scientific Corporation
• Galil Medical, Inc.
• EDAP TMS S.A.
• Healthtronics, Inc.
• Medtronic, Plc
• Mermaid Medical, Inc.
• Mesonix, Inc.
• Neuwave Medical, Inc.
• Sonacare Medical, LLC (U.S.)
MAJOR TOC OF THE REPORT
Chapter One: Tumor Ablation Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three: Global Tumor Ablation Market Competition, by Players
Chapter Four: Global Tumor Ablation Market Size by Regions
Chapter Five: North America Tumor Ablation Revenue by Countries
Chapter Six: Europe Tumor Ablation Revenue by Countries
Chapter Seven: Asia-Pacific Tumor Ablation Revenue by Countries
Chapter Eight: South America Tumor Ablation Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Tumor Ablation by Countries
Chapter Ten: Global Tumor Ablation Market Segment by Type
Chapter Eleven: Global Tumor Ablation Market Segment by Application
Chapter Twelve: Global Tumor Ablation Market Size Forecast (2019-2026)
Browse Full Report with Facts and Figures of Tumor Ablation Market Report at: https://www.maximizemarketresearch.com/market-report/tumor-ablation-market/12788/
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Contact: +919607065656/ +919607195908